Significant throughput of LSA to advance IPA’s diversity- and data-driven drug development and to enrich LENSai™. VICTORIA, British Columbia — IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today announced that it has acquired the LSA® instrument platform from Carterra®, a leading provider of high-throughput large […]
Sapio’s no-code LIMS platform will support genomic sequencing projects carried out in Genseq’s CAP-accredited sequencing laboratory BALTIMORE, MD — Genseq, a Dublin-based, CAP-accredited laboratory providing a range of services for biopharma and clinical research, has adopted the science-aware™ lab informatics platform from Sapio Sciences to manage its next-generation sequencing (NGS) and biobanking workflows. Genseq intends to deploy Sapio’s LIMS (Laboratory Information Management System) functionality to automate […]
Global leader in Biopharma R&D chooses the Genedata Biopharma Platform to accelerate discovery timelines for protein-based modalities Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, announced today that Daiichi Sankyo, a global pharmaceutical company with corporate origins in Japan, has adopted Genedata Biologics® to automate its discovery workflows. The […]
The addition of the LSA increases Icosagen’s end-to-end service capabilities for drug companies developing therapeutics worldwide Tartu, Estonia and Salt Lake City, Utah, USA — Icosagen Group, an established research-driven organization providing services for the discovery and production of mammalian cell-derived biopharmaceuticals, today announced that it has acquired the LSA® platform from Carterra®, a leading provider of […]
Universidad de Costa Rica is live on SOPHiA GENETICS’ technology Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Universidad de Costa Rica El Centro de Investigación en Cirugía y Cáncer (CICICA) is now live on the SOPHiA DDM™ […]
LEIDEN, NL – Synexa Life Sciences, a global Clinical Laboratory Services provider for the biopharma industry, announces the integration of the Olink® Target immunoassays and the Olink® Signature Q100 instrument into its extensive suite of biomarker discovery platforms.The adoption of Olink Signature Q100 represents a significant step forward in Synexa’s commitment to providing leading biomarker […]
Nanologica has made the first delivery of the company’s non-silica-based purification media NLAB Siv™ to a customer in Asia against an order received in November. The value amounts to over MSEK 4. NLAB Siv™ is a non-silica-based purification media that has been developed together with a customer who sells a number of pharmaceutical products. NLAB Siv™ […]
The collaboration aims to continue to gain commercial traction after Nabsys announced the OhmX platform in October 2023. Providence, Rhode Island – Hitachi High-Tech America, Inc. (“HTA”), in conjunction with Nabsys, announces a strategic leap forward in genomics research through HTA’s planned acquisition of 50 OhmX instruments to support the joint “RAMP UP” program. RAMP […]
The company announced Bioma4me has implemented SOPHiA DDM™ to support its rare disorder testing capabilities Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Bioma4me, a Brazil-based company focused on genetic sequencing to drive precision medicine to the Brazilian […]
SEATTLE — Eurofins Genomics, a global leader in sequencing services, announces the opening of a new, certified sequencing lab in Bothell, Washington, serving the greater Seattle area. The facility leverages the Oxford Nanopore’s sequencing platform and its local proximity to deliver results within 12 hours from sample pickup. The company has already lined up 30 partner labs in Seattle and conducting […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
-
2023 Dividend Changes for Laboratory Tool Companies Reflect a Chink in the Armor
January 31, 2024 5:45 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
